These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Efficacy and safety of topical difluprednate in persistent diabetic macular edema. Kaur S; Yangzes S; Singh S; Sachdev N Int Ophthalmol; 2016 Jun; 36(3):335-40. PubMed ID: 26296375 [TBL] [Abstract][Full Text] [Related]
4. Trans-Tenon's retrobulbar triamcinolone acetonide infusion for refractory diabetic macular edema after vitrectomy. Koga T; Mawatari Y; Inumaru J; Fukushima M; Tanihara H Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1247-52. PubMed ID: 16021497 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of sub-Tenon's capsule injection of triamcinolone acetonide for refractory diabetic macular edema after vitrectomy. Sato H; Naito T; Matsushita S; Takebayashi M; Shiota H J Med Invest; 2008 Aug; 55(3-4):279-82. PubMed ID: 18797143 [TBL] [Abstract][Full Text] [Related]
6. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Sutter FK; Simpson JM; Gillies MC Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370 [TBL] [Abstract][Full Text] [Related]
7. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema. Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075 [TBL] [Abstract][Full Text] [Related]
8. Diode laser, vitrectomy and intravitreal triamcinolone. A comparative study for the treatment of diffuse non tractional diabetic macular edema. Parolini B; Panozzo G; Gusson E; Pinackatt S; Bertoldo G; Rottini S; Pignatto S Semin Ophthalmol; 2004; 19(1-2):1-12. PubMed ID: 15658006 [TBL] [Abstract][Full Text] [Related]
9. Time course of changes in retinal thickness and visual acuity after intravitreal triamcinolone acetonide for diffuse diabetic macular edema with and without previous macular laser treatment. Patelli F; Fasolino G; Radice P; Russo S; Zumbo G; DI Tizio FM; Frisone G; Marchi S Retina; 2005; 25(7):840-5. PubMed ID: 16205561 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal versus subtenon triamcinolone acetonide injection for diabetic macular edema: a systematic review and meta-analysis. Qi HP; Bi S; Wei SQ; Cui H; Zhao JB Curr Eye Res; 2012 Dec; 37(12):1136-47. PubMed ID: 22793880 [TBL] [Abstract][Full Text] [Related]
11. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema. Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344 [TBL] [Abstract][Full Text] [Related]
12. Predictive factors for short-term visual outcome after intravitreal triamcinolone acetonide injection for diabetic macular oedema: an optical coherence tomography study. Brasil OF; Smith SD; Galor A; Lowder CY; Sears JE; Kaiser PK Br J Ophthalmol; 2007 Jun; 91(6):761-5. PubMed ID: 17108013 [TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of intravitreal triamcinolone acetonide injection in macular edema associated with retinal vascular disorders. Tewari HK; Sony P; Chawla R; Garg SP; Venkatesh P Eur J Ophthalmol; 2005; 15(5):619-26. PubMed ID: 16167293 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of postvitrectomy intravitreal triamcinolone therapy for diabetic macular edema. Costa JF; Sousa K; Marques JP; Marques M; Cachulo ML; Silva R; Gomes N; Figueira J Eur J Ophthalmol; 2016 Aug; 26(5):485-90. PubMed ID: 26951531 [TBL] [Abstract][Full Text] [Related]
16. Pars plana vitrectomy with removal of posterior hyaloid face in treatment of refractory diabetic macular edema resistant to triamcinolone acetonide. Higuchi A; Ogata N; Jo N; Wada M; Matsumura M Jpn J Ophthalmol; 2006; 50(6):529-531. PubMed ID: 17180527 [TBL] [Abstract][Full Text] [Related]
17. Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion. Cekiç O; Chang S; Tseng JJ; Barile GR; Weissman H; Del Priore LV; Schiff WM; Weiss M; Klancnik JM Retina; 2005; 25(7):846-50. PubMed ID: 16205562 [TBL] [Abstract][Full Text] [Related]
18. Reduction in the frequency of intravitreal bevacizumab administrations achieved by posterior subtenon injection of triamcinolone acetonide in patients with diffuse diabetic macular edema. Shimura M; Yasuda K; Minezaki T; Noma H Jpn J Ophthalmol; 2016 Sep; 60(5):401-7. PubMed ID: 27306783 [TBL] [Abstract][Full Text] [Related]
19. Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema. Batioğlu F; Ozmert E; Parmak N; Celik S Int Ophthalmol; 2007 Oct; 27(5):299-306. PubMed ID: 17453151 [TBL] [Abstract][Full Text] [Related]
20. [Macular thickness analysis by optic coherence tomography in refractory diabetic macular edema treated with intravitreous triamcinolone]. Pinheiro A; Serracarbassa PD; Maia OO; Takahashi WY Arq Bras Oftalmol; 2007; 70(5):784-9. PubMed ID: 18157302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]